01 1Viatris
01 1TENOFOVIR DISOPROXIL FUMARATE (PROCESS-II)
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-14
Pay. Date : 2013-09-20
DMF Number : 27456
Submission : 2013-09-24
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE (PROCESS-II), with a corresponding US DMF Number 27456.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
